# OV01 Preference Label 3 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_297_Vasquell - Task 1, batch 20260615_082222).
Current status: DRAFT for read-and-own. No platform entry without Alexander's authorization for that exact step.

Studio-selected pair:
- Transcript A = 0.550, 14 steps, 6m 10s. A different trajectory from the PL1 and PL2 A.
- Transcript B = 0.450, 22 steps, 9m 25s. A different trajectory from the PL1 and PL2 B.
- Bundle IDs not shown in the pasted transcript; record from the download icons on submit.

Basis: both deliverable summaries read against `golden-OV01-v1.docx` and `grader-guidelines-OV01.txt`. The central capped failure for OV01 is continuing the carried-forward inpatient enoxaparin VTE prophylaxis at discharge (or carrying admission antibiotic dosing forward, or silently resuming or discontinuing a held agent). A 0.55 is a low-mid pass; B 0.45 is a floor in the 0.40 to 0.50 band. Decided against the central item with the conservative-margin calibration the skill requires.

KEY FINDING: A is better. The decisive axis is again the central enoxaparin item, and here the two diverge more clearly than the earlier pairs. A explicitly recognizes that enoxaparin "was not a home med, it's inpatient VTE prophylaxis," treats it as a change requiring a renal dose and a concrete stop plan, and adds that an SNF transfer would change whether prophylaxis continues at all. B instead calls the same order a "good call clinically" and groups it under "confirm, then likely sign," endorsing continuation of the carried-forward inpatient prophylaxis without recognizing it is inpatient-only. Neither discontinues it, so neither catches the trap, but A is clearly the more cautious and principle-aware handling while B more firmly commits the central failure, which is why A passes at 0.55 and B floors at 0.45. B earns a genuine point of its own, a full Spanish version of the patient instructions for this Spanish-preferred patient, but that does not touch the central capped failure. The margin is A+ rather than A++ because A still calls the prophylaxis "likely appropriate" and does not make the golden's affirmative move of discontinuing it.

VERDICT: A2 (A better). Button = A+ (one plus sign).

## Justification

Preferred output: A

Justification: The central failure for OV01 is continuing the carried-forward inpatient enoxaparin VTE prophylaxis at discharge. Neither output discontinues it, so both commit a version of the central failure, and the pair is decided on which version is less wrong. A recognizes that enoxaparin is inpatient VTE prophylaxis and not a home medication, treats it as a change requiring a renal dose and a concrete stop plan, and flags that an SNF transfer would change whether prophylaxis continues at all. B calls the same order a "good call clinically" and places it under "confirm, then likely sign," endorsing continuation without recognizing it is inpatient-only. A is therefore the more cautious and principle-aware handling of the central item, which is why A passes at 0.55 while B floors at 0.45. The margin is A+, not A++, because A still calls the prophylaxis "likely appropriate" and does not make the golden's affirmative move of discontinuing it.

Prompt adherence: Both go line by line over all fourteen orders, write plain-language patient instructions, and flag confirm-before-sign items. B additionally provides a Spanish version of the instructions, a real plus for this Spanish-preferred patient. Both answer the requested workflow, with a small edge to B on the bilingual instructions, but this is not the decisive axis.

Correctness: A is better, and this is the deciding dimension. Both correctly stop the carried-forward IV piperacillin-tazobactam, both hold metformin and empagliflozin and treat lisinopril as the defensible restart, both retain acetaminophen with no NSAID, both continue home insulin, and both note that the sulfa allergy excludes only TMP-SMX and not a cephalosporin. The difference is the central enoxaparin item: A identifies it as inpatient-only prophylaxis and treats it as a change, while B calls it a "good call clinically" and leans to signing it. Neither discontinues it, which is why this is not a clean catch, but A's handling is the less wrong of the two.

Completeness: Mixed, and it does not decide the pair. B adds the Spanish patient-instruction sheet; A adds the dropped CPAP and a more explicit antibiotic plan, naming the agent options, route, renal dose, defined soft-tissue duration, and the cancellation of the other two IV antibiotics. Both catch the two dropped home medications. Each is more complete on a different axis, so completeness is roughly even.

Methodology: Both read the full chart, reconcile against the MAR and the held-order set, and check the renal trend and the imaging against the reports. A's synthesis is more careful on the inpatient-only status of enoxaparin and on the antibiotic clean-up; B's pass endorses the enoxaparin as a good call and is thinner on the antibiotic specifics. The interpretive difference on the central item is what separates them.

Quality and clarity: Both are organized, chart-anchored, and sign-ready, with clear verdict groupings and a confirm-before-sign list. A is the more cautious document on the central item; B is well organized and bilingual but, on the central item, confidently endorses an order it should have questioned. The grader directs not to weight formatting, so this dimension is neutral.

Summary: A is preferred at A+ because it handles the central enoxaparin item more faithfully, recognizing it as inpatient-only prophylaxis and treating it as a change with a stop plan and an SNF reassessment, while B calls the same order a "good call clinically" and leans to signing it. B's Spanish instruction sheet is a real but non-central plus. The margin is A+ rather than A++ because neither transcript makes the golden's affirmative move of discontinuing the inpatient-only enoxaparin; A calls it "likely appropriate" pending clarification rather than stopping it.

## Guardrails (must survive any edit)
1. Preferred output is A. Button = A+ (one plus sign).
2. The decider is the central enoxaparin item. A recognizes it is inpatient-only prophylaxis and treats it as a change; B calls it a "good call clinically" and leans to signing it. Neither discontinues it, so do not recharacterize A as a clean catch.
3. Margin is A+ (A2), not A++ (A3): A does not affirmatively discontinue the inpatient-only enoxaparin; it calls it "likely appropriate." Not plain A either, because A is clearly more principle-aware on the central item and B floors at 0.45.
4. B's "good call clinically, confirm then likely sign" on the inpatient-only enoxaparin is the central-item error A avoids; B does not recognize it is not a home medication. Record that as the deciding gap.
5. Both are correct on the surrounding Section A items (stop pip-tazo, hold the oral agents, no NSAID, continue insulin, deep-culture-directed antibiotic, sulfa excludes only TMP-SMX, add back ferrous sulfate and cholecalciferol). A additionally catches CPAP; B additionally provides a Spanish instruction sheet. Do not treat the shared items or the bilingual sheet as the decider.
6. PL 3 of 3 for OV01. Transcripts A (0.550) and B (0.450) are both distinct from the PL1 and PL2 trajectories.

## Submit mechanics
Select A+ (one plus sign), paste the justification from "Preferred output: A" through the Summary into Comments, submit the preference, confirm it appears in submission history, then run Preference Labels AutoQC. Do not submit until Alexander authorizes this exact step.
